Skip to content Skip to footer
Join our LinkedIn Group and be part of the conversation on AI in life sciences
Login
Login
Close

Meghan Oates-Zalesky 

Meghan Oates‑Zalesky is Chief Marketing Officer at CapeStart and MadeAi, with over 20 years of experience in healthcare technology and life sciences. Previously CMO at Apollo Intelligence, she helped grow the company from a small startup into a global enterprise. A PharmaVOICE Woman of Influence (2021), Meg’s thought leadership has appeared in leading industry publications. She holds degrees from Harvard and the London School of Economics and is a published novelist and avid equestrian.

83 articles published Follow:
MadeAi | AI Initiatives in Action: Insights from CapeStart's Life Science AI Research Report

AI Initiatives in Action: Insights from CapeStart’s Life Science AI Research Report

BlogDecember 17, 2024204Views0Likes0Comments
Artificial Intelligence (AI) is no longer a concept of the future—it's firmly entrenched in the here and now. CapeStart’s Life Science AI Research Report examines how actively life science professionals involved in AI initiatives. The findings underscore how AI is gradually transforming businesses, particularly in the life sciences industry. Engagement in AI Initiatives: A Snapshot…

Read More

lr

Life Science Professionals’ Perspectives on AI: Insights from CapeStart’s GenAI Report

BlogDecember 10, 2024205Views0Likes0Comments
Artificial Intelligence (AI) is making waves in industries worldwide, but how do professionals in life sciences feel about its potential? According to CapeStart’s Life Science AI Research Report, a resounding 91% of respondents believe that AI can assist and empower their work. This overwhelming optimism highlights a strong recognition of AI’s transformative capabilities. Belief in…

Read More

How CapeStart Streamlined Literature Review at Top 20 Pharmaceutical Manufacturer with GenAI-enabled Solution

CapeStart’s GenAI Solution Streamlines Literature Review for Top 20 Pharmaceutical Manufacturer

Case StudyDecember 2, 2024282Views0Likes0Comments
The clinical team for existing products at “ABC Pharma,” a top 20 pharmaceutical manufacturer, needed an automated solution for processing large volumes of medical literature across multiple therapeutic areas. Their internal development efforts had proved costly and unsuccessful. Requiring a comprehensive platform that could handle diverse literature types, support Health Authority inquiries, process content across ten…

Read More

How CapeStart Accelerated a Regulatory Submissions Through GenAI-Enabled Literature Review

How CapeStart Accelerated a Regulatory Submissions Through GenAI-Enabled Literature Review

Case StudyNovember 15, 2024257Views0Likes0Comments
A leading biotech company, faced critical challenges in their regulatory submission process. They needed to conduct a comprehensive clinical literature review and create a Clinical Evaluation Report (CER) with limited time and resources. The biotech company turned to CapeStart, who provided a hybrid approach combining expert analysis with their GenAI-powered MadeAi™ platform for literature review. Check-out…

Read More